568 results match your criteria: "Rigshospitalet Copenhagen University[Affiliation]"

Article Synopsis
  • Pain is common after TransOral Robotic Surgery (TORS), especially affecting swallowing, but current pain management techniques are not well understood.
  • A clinical trial tested the effects of high-dose versus low-dose dexamethasone on pain intensity and various secondary outcomes in patients undergoing TORS lingual tonsillectomy.
  • Results showed no significant differences in pain levels or secondary outcomes between the two dexamethasone groups, highlighting a need for further research in optimizing pain management after TORS.
View Article and Find Full Text PDF

Background: The reported hospital length of stay (LOS) following transoral robotic surgery lingual tonsillectomy (TORS-L) is variable, with limited understanding of the factors requiring hospitalization and no evidence-based criteria for discharge.

Aims/objectives: This observational cohort study investigated factors hindering discharge following TORS-L in a well-defined postoperative care program.

Methods: Patients were included between August 2020 and October 2022.

View Article and Find Full Text PDF

Dental implant treatment in patients with cancer on high-dose antiresorptive medication: A prospective feasibility study with 2 years follow-up.

Clin Oral Implants Res

January 2024

Research Area Oral Rehabilitation, Section for Oral Health, Society and Technology, Faculty of Health and Medical Sciences, Institute of Odontology, University of Copenhagen, Copenhagen, Denmark.

Objectives: Dental implant treatment is considered contraindicated in patients with cancer on high-dose antiresorptive medication (HDAR). The aim of this prospective, feasibility study was to evaluate implant treatment in patients with cancer on HDAR, in terms of implant survival, implant success, and oral health-related quality of life (OHLQoL) after 2 years of loading.

Materials And Methods: Implants were inserted in three groups of HDAR patients: (1) Previous tooth extraction, no medication-related osteonecrosis of the jaw (MRONJ), (2) Previous MRONJ, now healed, (3) Existing MRONJ, planned surgical resection.

View Article and Find Full Text PDF

Patients with end-stage kidney disease may require creation of an arteriovenous fistula in order to receive hemodialysis treatment. The creation may result in several complications, including carpal tunnel syndrome. Early diagnosis and treatment are essential to relieve symptoms, prevent permanent nerve damage, and improve quality of life.

View Article and Find Full Text PDF
Article Synopsis
  • Gastric cancer (GC) in elderly patients is a significant global health issue, leading to higher risks of complications and negative outcomes due to frailty and treatment effects.
  • A new study is being conducted to compare a multimodal prehabilitation program combined with the Enhanced Recovery After Surgery (ERAS) pathway against standard ERAS treatment in 368 older patients with GC, focusing on improving recovery outcomes.
  • The study aims to evaluate the impact of the prehabilitation program on postoperative complications, survival rates, functional capacity, and overall quality of life for these patients.
View Article and Find Full Text PDF

Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan.

ESC Heart Fail

February 2024

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

Article Synopsis
  • * In the PARAGON-HF study, patients with left ventricular ejection fraction of ≥45% were analyzed, showing that higher RDW levels were linked to worse clinical outcomes, including increased hospitalizations and cardiovascular deaths.
  • * The study found that sacubitril/valsartan reduced RDW more effectively than valsartan over 48 weeks, adding valuable prognostic information to existing predictors without changing the effects based on initial RDW levels.
View Article and Find Full Text PDF

Untreated fresh cardiac tissue is the optimal tissue material for investigating DNA methylation patterns of cardiac biology and diseases. However, fresh tissue is difficult to obtain. Therefore, tissue stored as frozen or formalin-fixed, paraffin-embedded (FFPE) is widely used for DNA methylation studies.

View Article and Find Full Text PDF

Study Question: Which add-ons are safe and effective to be used in ART treatment?

Summary Answer: Forty-two recommendations were formulated on the use of add-ons in the diagnosis of fertility problems, the IVF laboratory and clinical management of IVF treatment.

What Is Known Already: The innovative nature of ART combined with the extremely high motivation of the patients has opened the door to the wide application of what has become known as 'add-ons' in reproductive medicine. These supplementary options are available to patients in addition to standard fertility procedures, typically incurring an additional cost.

View Article and Find Full Text PDF

A survey of preferences for respiratory support in the intensive care unit for patients with acute hypoxaemic respiratory failure.

Acta Anaesthesiol Scand

November 2023

Department of Anaesthesiology and Intensive Care Medicine, Division of Emergencies and Critical Care, Rikshopitalet, Oslo University Hospital, Oslo, Norway.

Background: When caring for mechanically ventilated adults with acute hypoxaemic respiratory failure (AHRF), clinicians are faced with an uncertain choice between ventilator modes allowing for spontaneous breaths or ventilation fully controlled by the ventilator. The preferences of clinicians managing such patients, and what motivates their choice of ventilator mode, are largely unknown. To better understand how clinicians' preferences may impact the choice of ventilatory support for patients with AHRF, we issued a survey to an international network of intensive care unit (ICU) researchers.

View Article and Find Full Text PDF

Biofilm formation on endovascular aneurysm repair (EVAR) grafts-a proof of concept in vitro model.

Clin Microbiol Infect

December 2023

Department of Clinical Microbiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark; Costerton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Objectives: An endovascular aneurysm repair (EVAR) graft is a catheter-implanted vascular prosthesis and is the preferred treatment for patients with aortic aneurysm. If an EVAR graft becomes the focus of infection, the treatment possibilities are limited because it is technically difficult to remove the graft to obtain source control. This study examines whether Pseudomonas aeruginosa and Staphylococcus aureus form biofilm on EVAR prostheses.

View Article and Find Full Text PDF

Purpose: Selinexor inhibits exportin-1 (XPO1) resulting in nuclear accumulation of tumor suppressor proteins including p53 and has clinical activity in endometrial cancer (EC). The primary end point was to assess progression-free survival (PFS) with once-weekly oral selinexor in patients with advanced or recurrent EC.

Patients And Methods: ENGOT-EN5/GOG-3055/SIENDO was a randomized, prospective, multicenter, double-blind, placebo-controlled, phase III study at 107 sites in 10 countries.

View Article and Find Full Text PDF

Background: A predominant side effect of radiotherapy for head and neck cancer is salivary gland hypofunction and xerostomia leading to debilitating oral disorders and impaired quality of life (QoL). Intraglandular mesenchymal stem cell therapy has shown promising results as a treatment for xerostomia.

Methods: This is a randomised, double-blinded, placebo-controlled, parallel-group, prospective, single-centre trial investigating the safety, tolerability, and effectiveness of allogeneic stem cells as a treatment for radiation-induced hyposalivation and xerostomia for previous head and neck cancer patients.

View Article and Find Full Text PDF

Background: HER2 mutations are targetable alterations in patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC). In the SUMMIT basket study, patients with HER2-mutant MBC received neratinib monotherapy, neratinib + fulvestrant, or neratinib + fulvestrant + trastuzumab (N + F + T). We report results from 71 patients with HR+, HER2-mutant MBC, including 21 (seven in each arm) from a randomized substudy of fulvestrant versus fulvestrant + trastuzumab (F + T) versus N + F + T.

View Article and Find Full Text PDF

Background: Non-alcoholic fatty liver disease (NAFLD), and particularly liver fibrosis, has been suggested as a risk factor of chronic kidney disease (CKD). Given that NAFLD affects every fourth person globally, better insight is needed. Our aim was to investigate the association between hepatic fibrosis and CKD in patients with type 2 diabetes and to compare different methods for diagnosing liver fibrosis in this study population.

View Article and Find Full Text PDF
Article Synopsis
  • * The European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model' organized a two-day conference to promote collaboration among physicians and researchers.
  • * The conference focused on important areas such as preclinical models, treatment methods (surgery and radiation), genetic profiling, molecular tumor classification, and establishing a cancer registry.
View Article and Find Full Text PDF

RNA localization is essential for regulating spatial translation, where RNAs are trafficked to their target locations via various biological mechanisms. In this review, we discuss RNA localization in the context of molecular mechanisms, experimental techniques and machine learning-based prediction tools. Three main types of molecular mechanisms that control the localization of RNA to distinct cellular compartments are reviewed, including directed transport, protection from mRNA degradation, as well as diffusion and local entrapment.

View Article and Find Full Text PDF
Article Synopsis
  • Acute heart failure leads to many urgent hospitalizations, increasing the risk of death and rehospitalization, which highlights the need for careful management before and after discharge.
  • * Optimizing patient care during and after hospitalization can help prevent future rehospitalizations by addressing lingering symptoms of heart failure and ensuring proper medication adjustments.
  • * The Heart Failure Association of the European Society of Cardiology aims to share new insights on managing patients with acute heart failure, focusing on the critical time around hospital discharge.
View Article and Find Full Text PDF

Molecular Representations in Machine-Learning-Based Prediction of PK Parameters for Insulin Analogs.

ACS Omega

July 2023

Novo Nordisk A/S, Global Drug Discovery, Research & Early Development (R&ED), Måløv 2760, Denmark.

Therapeutic peptides and proteins derived from either endogenous hormones, such as insulin, or de novo design via display technologies occupy a distinct pharmaceutical space in between small molecules and large proteins such as antibodies. Optimizing the pharmacokinetic (PK) profile of drug candidates is of high importance when it comes to prioritizing lead candidates, and machine-learning models can provide a relevant tool to accelerate the drug design process. Predicting PK parameters of proteins remains difficult due to the complex factors that influence PK properties; furthermore, the data sets are small compared to the variety of compounds in the protein space.

View Article and Find Full Text PDF

Nasogastric feeding tubes (NG-tubes) from neonates contain potentially pathogenic bacteria. Using culture-based techniques, we have previously determined that the usage duration of NG-tubes did not impact the colonization of the nasogastric tubes. In the present study, we performed 16S rRNA gene amplicon sequencing to evaluate the microbial profile of 94 used nasogastric tubes collected from a single neonatal intensive care unit.

View Article and Find Full Text PDF

Background: The impact of primary biliary cholangitis (PBC) on health-related quality of life (HRQOL) is poorly understood. The aim of this study was to compare HRQOL in Danish patients with PBC to the general population and to assess associations to clinical and laboratory data.

Methods: We conducted a single-centre, cross-sectional questionnaire study in patients with PBC using the SF-36 and EQ-5D-5L.

View Article and Find Full Text PDF

Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction.

JACC Heart Fail

October 2023

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

Background: Heart failure (HF) is associated with impaired physical function and poor quality of life and affects health status more profoundly than many other chronic diseases.

Objectives: The authors examined the effects of dapagliflozin on specific physical and social limitations as reported by patients in the DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial.

Methods: The effect of dapagliflozin on the change from baseline to 8 months in each of the individual physical and social activity limitation questions answered by patients completing the Kansas City Cardiomyopathy Questionnaire (KCCQ), and overall scores, were examined with mixed-effects models and responder analyses.

View Article and Find Full Text PDF
Article Synopsis
  • Ibrutinib + venetoclax treatment shows improved progression-free survival (PFS) compared to chlorambucil + obinutuzumab for older patients with untreated chronic lymphocytic leukemia (CLL).
  • The analysis highlights the importance of undetectable minimal residual disease (uMRD) post-treatment, showing significant rates of uMRD in patients receiving ibrutinib + venetoclax (40.6% in bone marrow and 43.4% in blood) compared to lower rates in the other treatment group.
  • High PFS rates were observed in patients treated with ibrutinib + venetoclax after one year, regardless of their MRD status or immunoglobulin heavy
View Article and Find Full Text PDF
Article Synopsis
  • The study reports long-term efficacy and safety of niraparib in patients with advanced ovarian cancer after first-line chemotherapy, comparing it to a placebo in a phase 3 trial.
  • With a median follow-up of 3.5 years, patients receiving niraparib showed significantly longer progression-free survival (PFS) compared to those on placebo, particularly in patients with homologous recombination deficiency (HRd).
  • While the treatment was associated with some serious side effects like thrombocytopenia and anemia, the long-term benefits of niraparib in delaying disease progression were evident, suggesting its potential as a strong option for this patient group.
View Article and Find Full Text PDF